The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma - Top-Institutions - MDSpire

The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma

  • By

  • Giuseppe Lucarelli

  • Francesco Lasorsa

  • Monica Rutigliano

  • Martina Milella

  • Marco Spilotros

  • Antonio d’Amati

  • Giuseppe Ingravallo

  • Felice Crocetto

  • Savio Domenico Pandolfo

  • Marco Fabiano

  • Matteo Ferro

  • Riccardo Autorino

  • Michele Battaglia

  • Pasquale Ditonno

  • April 23, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Pathology
    • Cancer Genomics

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urologic Oncology
    • Pathology
    • Translational Cancer Research

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Pathology
    • Genitourinary Cancer Research

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urologic Oncology
    • Pathology
    • Cancer Biology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urologic Oncology
    • Pathology
    • Translational Cancer Research

Original Source(s)

The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma

  • by Giuseppe Lucarelli, Francesco Lasorsa, Monica Rutigliano, Martina Milella, Marco Spilotros, Antonio d’Amati, Giuseppe Ingravallo, Felice Crocetto, Savio Domenico Pandolfo, Marco Fabiano, Matteo Ferro, Riccardo Autorino, Michele Battaglia, Pasquale Ditonno

  • April 23, 2025

Related Content

Assessment of the effectiveness and safety of anti-VEGF/VEGFR monotherapy versus its combination with immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma: a network meta-analysis

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

Living-donor kidney transplantation: comparison of robotic-assisted versus conventional open technique in obese recipients